Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | Rho-associated, coiled-coil containing protein kinase 2 | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | sap-102, putative | 0.0055 | 0 | 0.5 |
Echinococcus multilocularis | MAGUK p55 subfamily | 0.0066 | 0.0228 | 0.0807 |
Trypanosoma brucei | guanylate kinase, putative | 0.0055 | 0 | 0.5 |
Trypanosoma cruzi | guanylate kinase, putative | 0.0055 | 0 | 0.5 |
Brugia malayi | Guanylate kinase family protein | 0.0066 | 0.0228 | 0.0228 |
Loa Loa (eye worm) | hypothetical protein | 0.0142 | 0.1782 | 0.1782 |
Mycobacterium ulcerans | guanylate kinase | 0.0055 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0066 | 0.0228 | 0.0228 |
Loa Loa (eye worm) | hypothetical protein | 0.0139 | 0.1715 | 0.1715 |
Chlamydia trachomatis | guanylate kinase | 0.0055 | 0 | 0.5 |
Trichomonas vaginalis | discs large, putative | 0.0055 | 0 | 0.5 |
Echinococcus granulosus | disks large 3 | 0.0066 | 0.0228 | 0.0807 |
Giardia lamblia | Guanylate kinase | 0.0055 | 0 | 0.5 |
Leishmania major | guanylate kinase, putative | 0.0055 | 0 | 0.5 |
Echinococcus granulosus | membrane associated guanylate kinase ww and pdz | 0.0139 | 0.1715 | 0.6065 |
Onchocerca volvulus | 0.0175 | 0.2457 | 0.9966 | |
Trichomonas vaginalis | calcium/calmodulin-dependent serine protein kinase membrane-associated guanylate kinase, putative | 0.0055 | 0 | 0.5 |
Echinococcus multilocularis | membrane associated guanylate kinase, WW and PDZ | 0.0139 | 0.1715 | 0.6065 |
Wolbachia endosymbiont of Brugia malayi | guanylate kinase | 0.0055 | 0 | 0.5 |
Echinococcus granulosus | peripheral plasma membrane protein CASK | 0.0066 | 0.0236 | 0.0834 |
Echinococcus granulosus | 55 kDa erythrocyte membrane protein | 0.0066 | 0.0228 | 0.0807 |
Schistosoma mansoni | ATP-dependent RNA Helicase | 0.0066 | 0.0228 | 0.0807 |
Echinococcus multilocularis | MAGUK p55 subfamily | 0.0066 | 0.0228 | 0.0807 |
Brugia malayi | Guanylate kinase family protein | 0.0066 | 0.0228 | 0.0228 |
Loa Loa (eye worm) | guanylate kinase | 0.0066 | 0.0228 | 0.0228 |
Plasmodium vivax | guanylate kinase, putative | 0.0055 | 0 | 0.5 |
Schistosoma mansoni | maguk P55 subfamily member 26 | 0.0066 | 0.0228 | 0.0807 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0176 | 0.2464 | 0.8714 |
Echinococcus granulosus | MAGUK p55 subfamily | 0.0066 | 0.0228 | 0.0807 |
Echinococcus granulosus | rho-associated protein kinase 1 | 0.0176 | 0.2464 | 0.8714 |
Echinococcus granulosus | membrane associated guanylate kinase ww and pdz | 0.0194 | 0.2828 | 1 |
Loa Loa (eye worm) | peripheral plasma membrane protein CASK | 0.0066 | 0.0228 | 0.0228 |
Leishmania major | guanylate kinase-like protein | 0.0055 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable guanylate kinase Gmk | 0.0055 | 0 | 0.5 |
Schistosoma mansoni | cell polarity protein | 0.0066 | 0.0228 | 0.0807 |
Schistosoma mansoni | membrane associated guanylate kinase inverted related | 0.0194 | 0.2828 | 1 |
Onchocerca volvulus | 0.0176 | 0.2464 | 1 | |
Echinococcus multilocularis | membrane associated guanylate kinase ww and pdz | 0.0139 | 0.1715 | 0.6065 |
Echinococcus granulosus | MAGUK p55 subfamily | 0.0066 | 0.0228 | 0.0807 |
Loa Loa (eye worm) | AGC/DMPK/ROCK protein kinase | 0.0546 | 1 | 1 |
Mycobacterium leprae | Probable guanylate kinase Gmk (GMP kinase). | 0.0055 | 0 | 0.5 |
Brugia malayi | PDZ domain containing protein | 0.0142 | 0.1782 | 0.1782 |
Entamoeba histolytica | guanylate kinase, putative | 0.0055 | 0 | 0.5 |
Schistosoma mansoni | maguk P55 subfamily member 35 | 0.0066 | 0.0228 | 0.0807 |
Schistosoma mansoni | membrane associated guanylate kinase inverted related | 0.0139 | 0.1715 | 0.6065 |
Echinococcus granulosus | membrane associated guanylate kinase, WW and PDZ | 0.0139 | 0.1715 | 0.6065 |
Echinococcus granulosus | 3'partial|membrane associated guanylate kinase ww and pdz | 0.0139 | 0.1715 | 0.6065 |
Trichomonas vaginalis | guanylate kinase, putative | 0.0055 | 0 | 0.5 |
Plasmodium falciparum | guanylate kinase | 0.0055 | 0 | 0.5 |
Brugia malayi | Peripheral plasma membrane protein CASK | 0.0066 | 0.0228 | 0.0228 |
Echinococcus multilocularis | 0.0194 | 0.2828 | 1 | |
Toxoplasma gondii | guanylate kinase family protein | 0.0055 | 0 | 0.5 |
Echinococcus multilocularis | disks large 3 | 0.0066 | 0.0228 | 0.0807 |
Echinococcus multilocularis | MAGUK p55 subfamily | 0.0066 | 0.0228 | 0.0807 |
Echinococcus granulosus | MAGUK p55 subfamily | 0.0066 | 0.0228 | 0.0807 |
Schistosoma mansoni | MAGUK homolog | 0.0066 | 0.0236 | 0.0834 |
Trypanosoma brucei | guanylate kinase, putative | 0.0055 | 0 | 0.5 |
Schistosoma mansoni | MAGUK homolog | 0.0066 | 0.0228 | 0.0807 |
Echinococcus multilocularis | peripheral plasma membrane protein CASK | 0.0066 | 0.0236 | 0.0834 |
Echinococcus multilocularis | rho associated protein kinase | 0.0176 | 0.2464 | 0.8714 |
Echinococcus multilocularis | 55 kDa erythrocyte membrane protein | 0.0066 | 0.0228 | 0.0807 |
Trypanosoma cruzi | guanylate kinase, putative | 0.0055 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 22.5 nM | BindingDB_Patents: Luciferin-Luciferase Assay. The activity of ROCKII (1-543) kinase is measured utilizing Cambrex PKLight ATP Detection Reagent, a homogeneous assay technology using luciferin-luciferase to quantify residual ATP. The assay is performed in 384-well low-volume, white, non-binding surface microtiter plates (Corning). The assay buffer is 25 mM HEPES, pH 7.5, 10 mM MgCl2, 50 mM KCl, 0.2% BSA, 0.01% CHAPS, 100 µM Na3VO4 and 0.5 mM DTT. Test compounds, dissolved in neat DMSO at 500 µg/mL, are serially diluted for dose response for a final starting concentration of 3 µg/mL in 1% DMSO of assay buffer. ROCKII (1-543) (62,408 Da) is diluted in assay buffer to a final concentration of 7.5 nM in a total volume of 15 µL. | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.